drugset / Trial / NCT00133874
Topical SB-275833 Ointment, 1% For The Treatment Of Impetigo
RandomizedSingle-groupSingle-blindTreatment
Summary
The goal of this study is to determine if topical SB-275833 ointment, 1% is as safe and effective as topical sodium fusidate ointment, 2% for the treatment of impetigo in adults and children as young as 9 months of age.
Timeline
- Start
- 2005-04
- Primary completion
- 2005-09
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Retapamulin | Small molecule | 1 % | Topical |